Preparation of mannan modified anionic PCL-PEG-PCL nanoparticles at one-step for bFGF antigen delivery to improve humoral immunity

Colloids and Surfaces B: Biointerfaces

Volumn 64, Issue 1, 2008, Pages 135-139

  Gou, MaLing ^a   Dai, Mei ^a   Li, XingYi ^a   Yang, Li ^a   Huang, MeiJuan ^a   Wang, YongShen ^a   Kan, Bing ^a   Lu, You ^a   Wei, YuQuan ^a   Qian, ZhiYong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Anionic nanoparticles; bFGF; DCs; Humoral immunity; Mannan; PCL PEG PCL

Indexed keywords

ANTIGENS; CHEMICAL MODIFICATION; ELECTROSTATICS; EVAPORATION; FIBROBLASTS; PARTICLE SIZE; POLYSACCHARIDES; SOLVENTS; ZETA POTENTIAL;

ANIONIC NANOPARTICLES; HUMORAL IMMUNITY; IMMUNITY; MANNAN;

NANOPARTICLES;

BASIC FIBROBLAST GROWTH FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MACROGOL; MANNAN; NANOPARTICLE; POLYCAPROLACTONE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRICITY; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EVAPORATION; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

ANIMALS; ANTIGENS; DRUG DELIVERY SYSTEMS; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MANNANS; MICE; MICE, INBRED C57BL; NANOPARTICLES; POLYESTERS; POLYETHYLENE GLYCOLS;

MUS;

EID: 43049091851     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2007.12.014     Document Type: Article

References (34)

1. Poland G.A., Murray D., and Bonilla-Guerrero R. New vaccine development. Brit. Med. J. 324 (2002) 1315-1319
2. Moll H. Antigen delivery by dendritic cells. Int. J. Med. Microbiol. 294 (2004) 337-344
3. Moll H. Dendritic cells as a tool to combat infectious diseases. Immunol. Lett. 85 (2003) 153-157
4. Péter G., Bence R., György H., and E'va R. Targeting dendritic cells for priming cellular immunity responses. J. Mol. Recognit. 16 (2003) 299-317
5. Reddy S.T., Swartz M.A., and Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 27 (2005) 573-579
6. Avrameas A., McIlroy D., Hosmalin A., Autran B., Debre P., Monsigny M., Roche A.C., and Midoux P. Expression of a mannose/fucose membrane lectin on human dendritic cells. Eur. J. Immunol. 26 (1996) 394-400
7. Bowersock T.L., and Martin S. Vaccine delivery to animals. Adv. Drug Deliv. Rev. 38 (1999) 167-194
8. Gupta R.K. Aluminum compounds as vaccine adjuvants. Adv. Drug Deliv. Rev. 32 (1998) 155-172
9. Hanes J., Cleland J.L., and Langer R. New advances in microsphere-based single-dose vaccines. Adv. Drug Del. Rev. 28 (1997) 97-119
10. O'Hagan D.T., and Rappuoli R. Novel approaches to pediatric vaccine delivery. Adv. Drug Del. Rev. 58 (2006) 29-51
11. Singh M., and O'Hagan D.T. Recent advances in vaccine adjuvants. Pharmac. Res. 19 (2002) 715-728
12. Foged C., Arigita C., Sundblad A., Jiskoot W., Storm G., and Frokjaer S. Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine 22 (2004) 1903-1913
13. Jilek S., Merkle H.P., and Walter E. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv. Drug Del. Rev. 57 (2005) 377-390
14. Copland M.J., Baird M.A., Rades T., McKenzie J.L., Becker B., Reck F., Tyler P.C., and Davies M. Liposomal delivery of antigen to human dendritic cells. Vaccine 21 (2003) 883-890
15. Cui Z.R., and Mumper R.J. Topical immunization using nanoengineered genetic vaccines. J. Control Rel. 81 (2002) 173-184
16. Hagedorn M., and Bikfalvi A. Target molecules for anti-angiogenic therapy: from basic research to clinical trials. Crit. Rev. Oncol. Hematol. 34 (2000) 89-110
17. Plum S.M., Holaday J.W., Ruiz A., Madsen J.W., Fogler W.E., and Fortier A.H. Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development. Vaccine 19 (2000) 1294-1303
18. Wang L.L., Li J.J., Zheng Z.B., Liu H.Y., Du G.J., and Li S. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells. Eur. J. Pharmacol. 502 (2004) 1-10
19. Karlsen A.E., and Dyrbert T. Molecular mimicry between non-self, modified self and self in autoimmunity. Semin. Immunol. 10 (1998) 25-34
20. Liu J.Y., Wei Y.Q., Yang L., Zhao X., Tian L., Hou J.M., Ting N., et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 102 (2003) 1815-1823
21. Wei Y.Q., Huang M.J., Yang L., Zhao X., Tian L., et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 11545-11550
22. Lu Y., Wei Y.Q., Tian L., Zhao X., Yang L., Hu B., Kan B., Wen Y.J., Liu F., Deng H.X., Li J., Mao Y.Q., Lei S., Huang M.J., Peng F., Jiang Y., Zhou H., Zhou L.Q., and Luo F. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor. J. Immunol. 170 (2003) 3162-3170
23. O'Donnell P.B., and McGinity J.W. Preparation of microspheres by the solvent evaporation technique. Adv. Drug Del. Rev. 28 (1997) 25-42
24. Singh M., Briones M., Ott G., and O'Hagan D.T. Cationic microparticles: a potent delivery sustem for DNA vaccines. PNAS (U.S.A.) 97 (2000) 811-816
25. Kazzaz J., Neidleman J., Singh M., Ott G., and O'Hagan D.T. Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J. Control. Release 67 (2000) 347-356
26. Shakesheff K.M., Evora C., Soriano I., and Langer R. The adsorption of poly(vinyl alcohol) to biodegradable microparticles studied by X-ray photoelectron spectroscopy (XPS). J. Colloid Interface Sci. 185 (1997) 538-547
27. MJ Huang, ML Gou, ZY Qian, Y Lu, MJ Tu, YQ Wei. One-Step Preparation of Cationic Polymer Nanoparticles for Plasmid DNA Delivery. J Biomed Mater Res, Part A. In press, (doi:10.1002/jbm.a.31704).
28. Gou M.L., Huang M.J., Qian Z.Y., Dai M., Li X.Y., and Wei Y.Q. Preparation of anionic poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymeric nanoparticles as basic protein antigen carrier. Growth Factors 25 (2007) 202-208
29. Weich H.A., Iberg N., Klagsbrun M., and Folkman J. Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells. Growth Factors 2 (1990) 313-320
30. Messai I., and Delair T. Cationic biodegradable particles: Comparison of one or two step processes. Colloids Surf. A Physicochem. Eng. Aspects 278 (2006) 188-196
31. Cui Z.R., and Mumper R.J. Coating of cationized protein on engineered nanoparticles results in enhanced immune responses. Int. J. Pharm. 238 (2002) 229-239
32. Tan M.C., Mommaas A.M., Drifhout J.W., et al. Mannose receptor mediated uptake of antigens strongly enhances HLA2class II restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27 (1997) 2426-2435
33. Engering A., Cella J., Fluitsma M., et al. The mannose receptor function as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27 (1997) 2417-2425
34. Snapper C.M., and Paul W.E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236 (1987) 944-947